v3.26.1
Share Capital and Share Premium - Schedule of roll forward of number of shares outstanding (Details) - shares
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Reconciliation of number of shares outstanding [abstract]      
Number of shares outstanding at beginning of period (in shares) 60,760,957 59,194,488 55,395,856
Exercise of stock options (in shares) 986,507 1,478,225 1,137,439
Vesting of RSUs (in shares) 135,842 88,244 79,560
Number of shares outstanding at end of period (in shares) 61,883,306 60,760,957 59,194,488
Global public offering on Nasdaq      
Reconciliation of number of shares outstanding [abstract]      
New shares issued for private placement, initial public offering, public offering and underwriters' over-allotment option (in shares)     2,244,899
Over-allotment option exercised by underwriters      
Reconciliation of number of shares outstanding [abstract]      
New shares issued for private placement, initial public offering, public offering and underwriters' over-allotment option (in shares)     336,734